
Marsh & McLennan (MRSH): Durable Compounder Despite Rich Valuation
Marsh & McLennan is executing well across broking and consulting, with 2025 revenue of $26.98B and Q1 2026 growth still running at 8%. The stock looks like a quality compounder, but valuation and leverage keep the upside measured.










